Skip to main content
High RiskFDAfda-F-0633-2022UNDECLARED ALLERGEN

Natural Way Cheese Marble Cheese Curds, retail 12oz plastic bag UPC 8 10056 75022 0, 12 retail units per wholesale case, and sold in 10lb...

Category
Units Affected
0
Recall Date
January 12, 2022
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0633-2022.

The milk used in the cheese curd had been stored in a holding tank in excess of 72 hours, therefore exceeding the required 72 hour tank cleaning interval.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0633-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Natural Way Cheese or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0633-2022.

Natural Way Cheese

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Natural Way Cheese Recall FAQ

Natural Way Cheese is the subject of a dairy safety report: Natural Way Cheese Marble Cheese Curds, retail 12oz plastic bag UPC 8 10056 75022 0, 12 retail units per wholesale case, and sold in 10lb.... The notice was published on January 12, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.